Back

Acute safety and efficacy of ablation for atrial fibrillation in elderly patients by means of pulsed field ablation

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: treatment 5 - ablation Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Professor Antonio Dello Russo

Marche Polytechnic University of Ancona, Ancona (Italy)

7 More presentations in this session

Presentation thumbnail
Durability of pulmonary vein isolation after radiofrequency-balloon ablation
Doctor K. Plank (Frankfurt am Main, DE)
Abstract Slides Video
Presentation thumbnail
Gastric hypomotility after adjunctive pulmonary vein and posterior wall isolation using cryoballoon in patients with atrial fibrillation: case control study
Doctor M. Esato (Ogaki, JP)
Abstract Slides Video
Presentation thumbnail
Multielectrode catheter-based pulsed field ablation of persistent and long-standing persistent atrial fibrillation
Doctor D. Della Rocca (Brussels, BE)
Abstract
Presentation thumbnail
An international multicentre experience with the third-generation laser balloon system: safety, efficiency, and efficacy
Doctor L. Bartoli (Luebeck, DE)
Abstract Slides Video
Presentation thumbnail
Weight change does not impact the long-term outcomes following pulmonary vein isolation in obese patients with atrial fibrillation
Doctor D. Musat (Paramus, US)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation: treatment 5 - ablation

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
Safety and efficacy of pulse field ablation of atrial fibrillation in patients aged over 75 years
thumbnail
Congress Presentation
Ablation outcome in elderly women with atrial fibrillation undergoing pulsed-field ablation for electrical isolation of pulmonary veins and left atrial posterior wall
thumbnail
Congress Presentation
Not too old to be treated: electrophysiological study and catheter ablation in eldery patients.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources